KFP
KB Financial Partners Portfolio holdings
AUM
$350M
1-Year Return
19%
This Quarter Return
+6.1%
1 Year Return
+19%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$348M
AUM Growth
+$75.2M
(+28%)
Cap. Flow
+$59M
Cap. Flow
% of AUM
16.93%
Top 10 Holdings %
Top 10 Hldgs %
69.82%
Holding
677
New
516
Increased
83
Reduced
78
Closed
–
Top Buys
| 1 |
iShares MBS ETF
MBB
|
$10.4M |
| 2 |
PGIM Ultra Short Bond ETF
PULS
|
$6.58M |
| 3 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
$4.97M |
| 4 |
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
|
$3.61M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
$3.56M |
Top Sells
| 1 |
iShares MSCI Japan ETF
EWJ
|
$2.79M |
| 2 |
Invesco S&P 500 Pure Growth ETF
RPG
|
$1.4M |
| 3 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
$686K |
| 4 |
ARK Innovation ETF
ARKK
|
$647K |
| 5 |
CIT
CIT Group Inc.
CIT
|
$627K |
Sector Composition
| 1 | Technology | 4.95% |
| 2 | Financials | 4.32% |
| 3 | Industrials | 4.02% |
| 4 | Healthcare | 3.91% |
| 5 | Communication Services | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Henry Schein
HSIC
$8.42B
| $2K | ﹤0.01% |
30
-3,465
| -99% | -$231K |
|
602
Intercontinental Exchange
ICE
$99.8B
| $2K | ﹤0.01% |
+15
| New | +$2K |
|
603
IDEX
IEX
$12.4B
| $2K | ﹤0.01% |
+9
| New | +$2K |
|
604
International Flavors & Fragrances
IFF
$16.9B
| $2K | ﹤0.01% |
+12
| New | +$2K |
|
605
International Paper
IP
$25.7B
| $2K | ﹤0.01% |
+49
| New | +$2K |
|
606
Invesco
IVZ
$9.81B
| $2K | ﹤0.01% |
+108
| New | +$2K |
|
607
Kimberly-Clark
KMB
$43.1B
| $2K | ﹤0.01% |
+12
| New | +$2K |
|
608
Kinder Morgan
KMI
$59.1B
| $2K | ﹤0.01% |
+111
| New | +$2K |
|
609
Lumen
LUMN
$4.87B
| $2K | ﹤0.01% |
+140
| New | +$2K |
|
610
Southwest Airlines
LUV
$16.5B
| $2K | ﹤0.01% |
+55
| New | +$2K |
|
611
Monster Beverage
MNST
$61B
| $2K | ﹤0.01% |
+44
| New | +$2K |
|
612
Neogen
NEOG
$1.25B
| $2K | ﹤0.01% |
+40
| New | +$2K |
|
613
NOV
NOV
$4.95B
| $2K | ﹤0.01% |
+157
| New | +$2K |
|
614
Novo Nordisk
NVO
$245B
| $2K | ﹤0.01% |
+44
| New | +$2K |
|
615
Stryker
SYK
$150B
| $2K | ﹤0.01% |
+8
| New | +$2K |
|
616
Thomson Reuters
TRI
$78.7B
| $2K | ﹤0.01% |
+13
| New | +$2K |
|
617
Travelers Companies
TRV
$62B
| $2K | ﹤0.01% |
+12
| New | +$2K |
|
618
Tyson Foods
TSN
$20B
| $2K | ﹤0.01% |
+24
| New | +$2K |
|
619
Victoria's Secret
VSCO
$2.1B
| $2K | ﹤0.01% |
+30
| New | +$2K |
|
|
WBA
620
DELISTED
Walgreens Boots Alliance
WBA
| $2K | ﹤0.01% |
+39
| New | +$2K |
|
621
Xylem
XYL
$34.2B
| $2K | ﹤0.01% |
+19
| New | +$2K |
|
622
Ameriprise Financial
AMP
$46.1B
| $1K | ﹤0.01% |
+2
| New | +$1K |
|
623
Vornado Realty Trust
VNO
$7.93B
| $1K | ﹤0.01% |
+34
| New | +$1K |
|
624
BioNTech
BNTX
$27B
| $1K | ﹤0.01% |
+2
| New | +$1K |
|
625
Celanese
CE
$5.34B
| $1K | ﹤0.01% |
+4
| New | +$1K |
|